Page last updated: 2024-08-23

paroxetine and olanzapine

paroxetine has been researched along with olanzapine in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	34 (77.27)	29.6817
2010's	10 (22.73)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Ahman, M; Holmén, AG; Wan, H	1
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Baldessarini, RJ; Tarazi, FI; Zhang, K	1
Kaschka, WP; König, F; Neuhöffer-Weiss, M; Petersdorff, T; von Hippel, C; Wolfersdorf, M	1
König, F; Raape, J; Truöl, S; Von Hippel, C	1
Kline, NA; Matloff, JL; Stein, MB	1
Arnone, D; Hansen, L; Kerr, JS	1
Downes, F; Isbister, GK; Whyte, IM	1
Cedro, C; D'Amico, G; D'Arrigo, C; Di Rosa, AE; La Torre, D; Muscatello, MR; Pandolfo, G; Spina, E; Zoccali, R	1
Gaisler-Salomon, I; Green, A; Joel, D; Schiller, D; Weiner, I	1
Christodoulou, GN; Havaki-Kontaxaki, BJ; Katritsis, DE; Kontaxakis, VP; Pappa, DA	1
Danielyan, A; Kowatch, RA; Pathak, S	1
Salerian, AJ	1
Chao, I	1
Goldstein, D; Green, S; Santangelo, CG	1
Campanella, D; Carano, A; Cicconetti, A; D'Amico, M; De Berardis, D; Ferro, FM; Gambi, F; La Rovere, R; Mancini, E; Peca, S; Penna, L; Salerno, RM; Sepede, G	1
de Bruijn, ER; Hulstijn, W; Ruigt, GS; Sabbe, BG; Verkes, RJ	1
Agius, M; Biocina-Martić, S; Dordević, V; Gruber, EN	1
Harada, M; Kubo, H; Ohmori, T; Sumitani, S	1
Hulstijn, W; Morrens, M; Ruigt, GS; Sabbe, BG; Verkes, RJ; Wezenberg, E	1
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J	1
Alfirevic, Z; Degoricija, V; Vucicevic, Z; Vukicevic-Badouin, D	1
Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G	1
Nagata, T; Nakayama, K; Ono, K	1
Miller, KM; Murray, KL; Pearson, DL	1
Hori, H; Kodama, Y; Nakamura, J; Nakano, H; Sugita, A; Ueda, N; Umene, W; Yoshimura, R	1
Furukawa, TA; Murata, Y; Nakaaki, S	1
Conrad, R; Geiser, F; Imbierowicz, K; Liedtke, R; Wegener, I	1
Gutierrez, AM; Mohammadi, M; Weber, M	1
Dadić-Hero, E; Kabalin, M; Medved, P; Pernar, M; Ruzić, K	1
Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ	1
Dadić-Hero, E; Grahovac, T; Petranović, D; Ružić, K; Valković, T	1
Janas-Kozik, M; Krupka-Matuszczyk, I; Krzystanek, E; Krzystanek, M; Małecki, A; Rybakowski, JK; Trzeciak, HI	1
Amianto, F; Brambilla, F; Dalle Grave, R; Fassino, S	1
Belcher, DC; Dowben, JS; Keltner, NL; Kowalski, PC	1
Konstantinou, G; Mylona, S; Paschalakis, G; Stavrinou, A; Vasilopoulou, P	1

Reviews

2 review(s) available for paroxetine and olanzapine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Biological Perspectives: Huntington's Disease. Perspectives in psychiatric care, 2015, Volume: 51, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Cognition Disorders; Dementia; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Memory, Short-Term; Mood Disorders; Olanzapine; Paroxetine	2015

Trials

9 trial(s) available for paroxetine and olanzapine

Article	Year
First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression. Neuropsychobiology, 2001, Volume: 43, Issue:3 Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Inpatients; Male; Middle Aged; Olanzapine; Paroxetine; Patient Discharge; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2001
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. The American journal of psychiatry, 2002, Volume: 159, Issue:10 Topics: Antipsychotic Agents; Benzodiazepines; Combat Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Paroxetine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Treatment Outcome	2002
Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:4 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Pirenzepine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain	2003
Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Adult; Agoraphobia; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure	2006
Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers. Brain research, 2006, Aug-11, Volume: 1105, Issue:1 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Brain Mapping; Contingent Negative Variation; Double-Blind Method; Electroencephalography; Female; Haloperidol; Humans; Linear Models; Male; Monitoring, Physiologic; Olanzapine; Paroxetine; Reaction Time	2006
Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Memory; Olanzapine; Paroxetine; Psychomotor Performance; Reference Values	2007
Motor cortex excitability after vagus nerve stimulation in major depression. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid	2007
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:6 Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult	2009
Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background. BMC psychiatry, 2014, Dec-24, Volume: 14 Topics: Administration, Oral; Adult; Analysis of Variance; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Bulimia Nervosa; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Olanzapine; Paroxetine; Psychotherapy, Brief; Serotonin Plasma Membrane Transport Proteins; Treatment Failure	2014

Other Studies

33 other study(ies) available for paroxetine and olanzapine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physical binding pocket induction for affinity prediction. Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19 Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain. Neuroscience letters, 2000, Jun-23, Volume: 287, Issue:2 Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Carrier Proteins; Caudate Nucleus; Cocaine; Dibenzothiazepines; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Olanzapine; Paroxetine; Pirenzepine; Prosencephalon; Putamen; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tritium	2000
[Improvement of tardive dyskinesia after treatment with olanzapine]. Psychiatrische Praxis, 2002, Volume: 29, Issue:6 Topics: Affective Disorders, Psychotic; Aged; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Neurologic Examination; Olanzapine; Paroxetine; Patient Admission; Pirenzepine	2002
Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:4 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dystonic Disorders; Electroconvulsive Therapy; Humans; Male; Morpholines; Olanzapine; Paroxetine; Pirenzepine; Reboxetine	2002
Olanzapine and serotonin toxicity. Psychiatry and clinical neurosciences, 2003, Volume: 57, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Citalopram; Drug Therapy, Combination; Humans; Olanzapine; Paroxetine; Pirenzepine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome	2003
A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behavioural pharmacology, 2003, Volume: 14, Issue:3 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Clozapine; Conditioning, Psychological; Haloperidol; Imipramine; Inhibition, Psychological; Male; Models, Animal; Olanzapine; Paroxetine; Pirenzepine; Rats; Rats, Wistar; Swimming	2003
Neuroleptic malignant syndrome after addition of paroxetine to olanzapine. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6 Topics: Benzodiazepines; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Paroxetine; Selective Serotonin Reuptake Inhibitors	2003
Successful treatment of trichotillomania with olanzapine augmentation in an adolescent. Journal of child and adolescent psychopharmacology, 2004,Spring, Volume: 14, Issue:1 Topics: Adolescent; Behavior Therapy; Benzodiazepines; Comorbidity; Drug Therapy, Combination; Female; Humans; Olanzapine; Paroxetine; Sertraline; Trichotillomania	2004
Successful treatment of sexual dysfunction with dronabinol: a case report. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:8 Topics: Adult; Benzodiazepines; Bipolar Disorder; Dronabinol; Female; Humans; Libido; Olanzapine; Paroxetine; Psychotropic Drugs; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome; Valproic Acid	2004
Olanzapine augmentation in panic disorder: a case report. Pharmacopsychiatry, 2004, Volume: 37, Issue:5 Topics: Agoraphobia; Benzodiazepines; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Olanzapine; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2004
A case of bipolar disorder and typhoid fever. International journal of psychiatry in medicine, 2004, Volume: 34, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Neuropsychological Tests; Olanzapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Typhoid Fever	2004
"My new Alfa Romeo GT is not in the garage any more": Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis. Psychiatria Danubina, 2006, Volume: 18, Issue:3-4 Topics: Adult; Agoraphobia; Antipsychotic Agents; Atenolol; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Diazepam; Hospitalization; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychotic Disorders; Reality Testing; Socialization	2006
Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry research, 2007, Jan-15, Volume: 154, Issue:1 Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia; Benzodiazepines; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Energy Metabolism; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Prefrontal Cortex; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy. International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:5 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Edema; Fatal Outcome; Fluphenazine; Haloperidol; Heart Arrest; Humans; Hyperglycemia; Hyponatremia; Inappropriate ADH Syndrome; Male; Mental Disorders; Olanzapine; Pancreatitis; Paroxetine; Polypharmacy; Selective Serotonin Reuptake Inhibitors	2007
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. Pharmacy world & science : PWS, 2008, Volume: 30, Issue:1 Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome	2008
Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder. Psychiatry and clinical neurosciences, 2007, Volume: 61, Issue:4 Topics: Anorexia Nervosa; Antidepressive Agents, Second-Generation; Benzodiazepines; Body Weight; Bulimia; Chronic Disease; Female; Hospitalization; Humans; Mianserin; Middle Aged; Olanzapine; Paroxetine; Schizotypal Personality Disorder; Selective Serotonin Reuptake Inhibitors	2007
Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine. Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:8 Topics: Antidepressive Agents, Second-Generation; Benzodiazepines; Clonazepam; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Olanzapine; Paroxetine; Respiratory Insufficiency; Serotonin Syndrome	2007
Two cases of burning mouth syndrome treated with olanzapine. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:3 Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Burning Mouth Syndrome; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Milnacipran; Olanzapine; Paroxetine; Treatment Outcome	2008
Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Body Image; Delusions; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine	2008
Nature against nurture: calcification in the right thalamus in a young man with anorexia nervosa and obsessive-compulsive personality disorder. CNS spectrums, 2008, Volume: 13, Issue:10 Topics: Adult; Anorexia Nervosa; Benzodiazepines; Calcinosis; Combined Modality Therapy; Dominance, Cerebral; Humans; Life Change Events; Male; Mediodorsal Thalamic Nucleus; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Psychotherapy; Thalamic Diseases; Tomography, X-Ray Computed	2008
The risks and benefits of switching antipsychotics: a case study approach. Perspectives in psychiatric care, 2009, Volume: 45, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertriglyceridemia; Long-Term Care; Male; Middle Aged; Olanzapine; Paroxetine; Psychotic Disorders; Risk Assessment; Schizophrenia; Thioridazine	2009
Olanzapine treatment in anorexia nervosa: case report. Psychiatria Danubina, 2009, Volume: 21, Issue:1 Topics: Adolescent; Ambulatory Care; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Body Weight; Combined Modality Therapy; Defense Mechanisms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; MMPI; Olanzapine; Paroxetine; Psychotherapy	2009
Treatment strategy in schizophrenia combined with eating disorder. Psychiatria Danubina, 2011, Volume: 23, Issue:1 Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Apathy; Benzodiazepines; Comorbidity; Cooperative Behavior; Disease Progression; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Interdisciplinary Communication; Mobility Limitation; Olanzapine; Paroxetine; Schizophrenia; Schizophrenic Psychology; Social Isolation; Vitamin B 12; Weight Loss	2011
Effects of olanzapine and paroxetine on phospholipase D activity in the rat brain. Pharmacological reports : PR, 2013, Volume: 65, Issue:3 Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cell Membrane; Cerebral Cortex; Male; Olanzapine; Paroxetine; Phospholipase D; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Selective Serotonin Reuptake Inhibitors	2013
Basal Ganglia Calcification: A Case Report of Fahr Disease With Pure Psychiatric Symptoms. Journal of psychiatric practice, 2019, Volume: 25, Issue:5 Topics: Basal Ganglia; Basal Ganglia Diseases; Calcinosis; Depression; Diagnosis, Differential; Female; Humans; Mental Disorders; Middle Aged; Neurodegenerative Diseases; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Psychotropic Drugs; Tomography, X-Ray Computed; Treatment Outcome	2019